BEAT · HeartBeam, Inc.
$0.50
-0.09 (-15.34%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the current business plan assumptions, existing financing arrangements and expected cash burn rate, the Company believes that its existing liquidity is insufficient to fund operations for the next twelve months following the issuance of these financial statements. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$28.14M
Shares
56.35M
HeartBeam, Inc. Earnings Call Transcripts
Every quarterly earnings call for HeartBeam, Inc. (BEAT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-13
Second Quarter 2026 Earnings Conference Call
Confident tone
Form factors (card, patch, remote unit) and use cases
Heart attack detection (MI) pivotal study and FDA submission
Integrated network partnerships (ER / hospital workflow)
Diluted EPS
$-0.10
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
First Quarter 2026 Earnings Conference Call
Confident tone
Heart Attack Detection (Align ACS)
Revenue Timing and Guidance
Clinical Feedback and Differentiation
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
Fourth Quarter 2025 Earnings Conference Call
Confident tone
Limited Commercial Launch in Concierge/Preventive Cardiology
12-Lead ECG Patch Platform
Heart Attack Detection Development
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q4
2025-12-31
HeartBeam, Inc. Q4 FY2025 Earnings Call
Confident tone
Limited Commercial Launch in Concierge/Preventive Cardiology
12-Lead ECG Patch Platform
Heart Attack Detection Development
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
HeartBeam, Inc. Q3 FY2025 Earnings Call
Confident tone
HeartNexus cardiology reader service agreement
Commercial launch and go-to-market strategy
FDA 510(k) clearance for 12-Lead synthesis software
Diluted EPS
$-0.15
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
HeartBeam, Inc. Q2 FY2025 Earnings Call
Confident tone
Product ecosystem
Commercial readiness and pilot launch
Competitive positioning
Diluted EPS
$-0.15
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
HeartBeam, Inc. Q1 FY2025 Earnings Call
Confident tone
AccurKardia collaboration
FDA 510(k) regulatory progress
VALID-ECG pivotal study
Diluted EPS
$-0.18
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
HeartBeam, Inc. Q4 FY2024 Earnings Call
Confident tone
Financing and capital
FDA clearance milestones
Commercialization strategy
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-09-30
HeartBeam, Inc. Q3 FY2024 Earnings Call
Positive tone
Technology and platform
Upcoming milestones
FDA submission and clearance
Diluted EPS
$-0.19
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
HeartBeam, Inc. Q2 FY2024 Earnings Call
Confident tone
AIMIGo product platform
FDA clearance progress for AIMIGo
Market opportunity and expansion roadmap
Diluted EPS
$-0.19
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
HeartBeam, Inc. Q1 FY2024 Earnings Call
Confident tone
FDA 510(k) clearance for AIMIGo
Valid ECG pivotal study
AI / deep learning algorithm development
Diluted EPS
$-0.17
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
HeartBeam, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
HeartBeam, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.13
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
HeartBeam, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.16
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
HeartBeam, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.50
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
HeartBeam, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
HeartBeam, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-0.44
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
HeartBeam, Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.43
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
HeartBeam, Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
HeartBeam, Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–20 of 20 earnings calls
Key facts
CIK
1779372
CUSIP
42238H108
13F (30d)
43 filings
43 filers
Visit website
Investor relations